Search Results

Displaying Results 201-225 of 349 "'BMI'"

Mar 18, 2026, 09:00 ET CVS Health Foundation Invests $2.24 Million to Strengthen Community Health in Charlotte's Historic West End

Collab aims to:Reduce preventable hospitalizationsImprove key health outcomes, including blood pressure, cholesterol and BMIConnect residents to integrated medical, nutrition, and social servicesDecrease food insecurity in the Historic West End (HWE)Expand

More news about: CVS Health


Mar 18, 2026, 08:00 ET MetaVia Advances GLP-1-Based Obesity Program with IRB Approval for Higher-Dose Phase 1 Studies of DA-1726, a GLP-1 and Glucagon Dual Agonist Demonstrating Best-in-Class Potential for Weight Loss and Glucose Control

PK profiling and evaluation of metabolic, glycemic, lipid, and body composition measures, including weight, waist circumference, and body mass index (BMI), and other cardiometabolic measures."This IRB approval marks a key milestone in the advancement of DA-1726 and builds on the program's increasingly

More news about: MetaVia Inc.


Mar 12, 2026, 09:05 ET BioMarin Presents New Data on the Positive Impact of Early Treatment With VOXZOGO® (vosoritide) on Proportionality and Arm Span in Children with Achondroplasia at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting

improvements compared to untreated children, which is particularly relevant in early life. Researchers also saw significant improvements in body mass index (BMI) in children who initiated treatment when compared to untreated children."It is encouraging to see increasing data on outcomes beyond height,

More news about: BioMarin Pharmaceutical Inc.


Mar 11, 2026, 12:28 ET COUNTRY MUSIC HALL OF FAME® AND MUSEUM TO OPEN NEW EXHIBITION, CLINT BLACK: THE HARD WAY ON PURPOSE

Napster took hold.About 50 years after he received his first harmonica, Black was officially named an icon. In November 2025, Broadcast Music Inc. (BMI) bestowed its prestigious Icon Award on Black in recognition of his "unique and indelible influence on music makers across generations."About

More news about: Country Music Hall of Fame and Museum


Mar 11, 2026, 10:00 ET Maven Is Opening Its Doors to Women Nationwide

Prescribing decisions consider reproductive history including conditions like PCOS, postpartum recovery, perimenopause, and future fertility plans, not just BMI.Members receive nutrition and strength guidance to help preserve muscle mass, manage side effects, and build habits that last. Care continues

More news about: Maven Clinic


Mar 10, 2026, 10:03 ET Carrum Health and Virta Health Partner to Deliver Seamless, Full-Spectrum Weight Management Solution for Self-Insured Employers

partnership will workConsider an employee who needs a knee or hip replacement but is clinically recommended to lower their body mass index (BMI) to a healthy range so they have the best surgical outcomes. They will then need to lose weight and come back when ready. Without connected services,

More news about: Carrum Health


Mar 10, 2026, 08:00 ET Dario Demonstrates Clinically Meaningful Blood Glucose Improvements and Personalized Glycemic Trajectories Across 22,000+ Users: Machine Learning Study Findings Published in Frontiers in Digital Health

influence glycemic improvement. Importantly, outcomes suggested broad across diverse user populations, as demonstrated with no meaningful body mass index ("BMI") difference across ethnicities.  Higher levels of digital engagement – specifically frequent blood glucose monitoring and lifestyle activities tags

More news about: DarioHealth Corp.


Mar 10, 2026, 06:00 ET 歌禮宣佈其小分子GLP-1R激動劑ASC30的超長效皮下儲庫型制劑針對肥胖適應症的美國II期24周研究獲積極頂線結果

0.05)和臨床意義的平均體重下降7.5%(經安慰劑校正後)。該II期研究為一項在美國開展的隨機、雙盲、安慰劑對照及多中心的為期24周的研究,旨在評估ASC30在65例肥胖受試者(體重指數BMI ≥ 30 kg/m²)或伴有至少一種體重相關合併症的超重受試者(27 kg/m² ≤ BMI < 30 kg/m²)中的安全性、耐受性及療效。65例受試者均在第1天、第29天(第4周)及第57天(第8周)接受每月一次的ASC30皮下儲庫型制劑或匹配的安慰劑給藥(共3劑),無需每週一次給藥的準備(lead-in)期。維持期從第8周開始至第24周,共16周。該研究對ASC30的兩種皮下儲庫型制劑(A1和A2)進行了評估,研究目的為評估每月一次給藥的治療療法和每季度一次給藥的維持療法的潛力。ASC30皮下儲庫型制劑A1此前已在一項為期12周的Ib期單劑量研究(

More news about: 歌禮製藥有限公司


Mar 10, 2026, 06:00 ET Ascletis Announces Positive Topline Results from U.S. Phase II, 24-Week Study for Its Ultra-Long-Acting Subcutaneous Depot Formulations of Small Molecule GLP-1R Agonist ASC30 for Obesity

study conducted in the U.S. to evaluate the safety, tolerability and efficacy in 65 participants with obesity (body mass index (BMI) ≥ 30 kg/m2) or overweight (BMI ≥ 27 kg/m2 but < 30 kg/m2) with at least one weight-related comorbidity. All 65 participants were given

More news about: Ascletis Pharma Inc.


Mar 09, 2026, 08:45 ET Meet Dr. Babajide Ogunseinde: Innovator Behind the PML SI Fusion Technique and the PML Mastery App

includes a voice narration of step-by-step of the technique as well as in the Journal of surgical case report and research on PMLSI fusion in patient with BMI > 30.Dr Ogunseinde is dedicated to teaching and launched the PML Mastery, an online platform surgical course for surgeons worldwide to teach

More news about: PML Mastery


Mar 09, 2026, 08:00 ET AbbVie Announces Positive Topline Results from a Phase 1 Multiple Ascending Dose Study of ABBV-295, a Long-Acting Amylin Analog, in Adults

evaluating the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of subcutaneous ABBV-295, in adults with a mean body mass index (BMI) of less than 30 kg/m2. ABBV-295 is a long-acting amylin analog that represents a mechanistically distinct class from incretin-based therapies

More news about: AbbVie


Mar 06, 2026, 15:44 ET Studies explore: GLP-1 receptor agonist use and its impact on long-term musculoskeletal health and orthopaedic surgical outcomes

carpal tunnel release, distal radius open reduction internal fixation (ORIF), and ankle ORIF. Analyses were stratified by obesity class (BMI = 30-39.9 and BMI ≥ 40). The study found a consistent increase in GLP-1 and semaglutide use among patients undergoing these procedures,

More news about: American Academy of Orthopaedic Surgeons


Mar 02, 2026, 10:53 ET Commercial Roofing Market to Surpass USD 20.44 Billion by 2032, Reveals New Maximize Market Research Analysis

GAF (United States)13. IKO Industries Ltd. (Canada)14. TAMKO Building Products Inc. (United States)Asia Pacific15. BMI Group – Everguard (India)16. Tremco Construction Products Group (Asia Pacific)17. LCP Building Products Pvt. Ltd. (India)18. Proflex

More news about: Maximize Market Research Pvt. Ltd.


Mar 02, 2026, 08:03 ET Decentralized Clinical Trial Validates Novel "Fasting Mimetic" Formulation for Cardiometabolic Health

decentralized clinical trial (RCT).Duration: 8 weeks.Participants: 42 adults (Average age 62 ± 4 years) with elevated BMI and HbA1c were recruited, with high retention rates.Endpoints:Biological: Comprehensive metabolic blood panels

More news about: People Science, Inc.


Mar 02, 2026, 08:02 ET Mimio Health Announces Breakthrough Clinical Trial Of Its Fasting Mimetic, Demonstrating Fasting-Like Benefits Without Dietary Changes

decentralized clinical trialDuration: 8 weeksParticipants: 42 adults (average age 62 ± 4 years) with elevated BMI and HbA1c, with high retention ratesEndpoints:Biological: Comprehensive metabolic blood panels (lipids, glucose,

More news about: Mimio Health, Inc.


Mar 02, 2026, 01:01 ET Robotic-assisted arthroplasty shows higher patient satisfaction and quality of life for total knee replacement; comparable infection rates to conventional surgery for total hip replacement

National Healthcare Safety Network criteria. Logistic regression was performed to control for known confounders, including age, gender, body mass index (BMI), surgical duration, surgical approach (anterior vs. posterior), diabetes and smoking history.Among the 31,795 primary THAs analyzed, 15,848 used

More news about: American Academy of Orthopaedic Surgeons


Feb 27, 2026, 07:17 ET PHYSICALMIND Institute lanserer den offentlige kunngjøringen «WELLVILLE» i det ny forskning indikerer at BMI kan være foreldet

En studie publisert i JAMA Network Open oppdaget at prevalensen av fedme, når det defineres via både kroppsmasseindeks (BMI) og midjeomkrets, øker fra omtrent 42–43 % til nesten 68–70 %. Den utvidede definisjonen har blitt godkjent av 76 organisasjoner, inkludert American

More news about: PhysicalMind Institute


Feb 27, 2026, 07:09 ET PHYSICALMIND Institute julkaisee "WELLVILLE" PSA:n uuden tutkimuksen osoittaessa, että painoindeksi saattaa olla vanhentunut

JAMA Network Open -lehdessä julkaistussa tutkimuksessa todettiin, että kun liikalihavuus määritellään sekä painoindeksin (BMI) että vyötärönympäryksen perusteella, sen esiintyvyys nousee noin 42–43 prosentista lähes 68–70 prosenttiin. Laajennettu määritelmä on saanut tukea 76

More news about: PhysicalMind Institute


Feb 27, 2026, 07:05 ET PHYSICALMIND Institute lancerer "WELLVILLE" PSA, da ny forskning tyder på, at BMI muligvis er forældet

En undersøgelse offentliggjort i JAMA Network Open viste, at når fedme defineres ved hjælp af både Body Mass Index (BMI) og taljemål, stiger forekomsten fra ca. 42-43 % til næsten 68-70 %. Den udvidede definition er blevet godkendt af 76 organisationer, herunder American

More news about: PhysicalMind Institute


Feb 27, 2026, 06:35 ET PHYSICALMIND Institute släpper public service-meddelandet "WELLVILLE" då ny forskning indikerar att BMI kan vara föråldrat

En studie som publicerades i JAMA Network Open visade att när fetma definieras med hjälp av både kroppsmassindex (Body Mass Index, BMI) och midjemått ökar prevalensen från cirka 42-43 % till nästan 68-70 %. Den utökade definitionen har godkänts av 76 organisationer, inklusive American

More news about: PhysicalMind Institute


Feb 26, 2026, 13:02 ET PHYSICALMIND Institute Launches "WELLVILLE" PSA as New Research Indicates BMI may be obsolete

A study published in JAMA Network Open found that when obesity is defined using both Body Mass Index (BMI) and waist circumference, prevalence rises from approximately 42–43% to nearly 68–70%. The expanded definition has been endorsed by 76 organizations,

More news about: PhysicalMind Institute


Feb 25, 2026, 08:00 ET BMI Imaging Exhibits at SACRAO 2026 Conference in Orlando

https://www.bmiimaging.com.About BMI Imaging SystemsFounded in 1958, BMI Imaging Systems helps colleges, universities, and public agencies convert paper, microfilm, and microfiche into secure, searchable digital collections. BMI provides public, private, and CJIS-compliant

More news about: BMI Imaging Systems, Inc.


Feb 25, 2026, 08:00 ET PrecisionLife and Ovation identify first potential genetic biomarkers to quantitatively predict GLP-1 efficacy response

strong and weak responders to GLP-1 RA drugs and quantitatively predict the level of efficacy based on their degree of response measured by BMI and HbA1c changes. While we see many known pathways, a number of the genes identified are outside of the "defined" GLP-1RA mechanisms of action and novel

More news about: PrecisionLife Ltd; Ovation.io


Feb 24, 2026, 13:38 ET PHYSICALMIND Institute Launches "WELLVILLE" PSA as New Research Indicates BMI may be obsolete

A study published in JAMA Network Open found that when obesity is defined using both Body Mass Index (BMI) and waist circumference, prevalence rises from approximately 42–43% to nearly 68–70%. The expanded definition has been endorsed by 76 organizations,

More news about: PhysicalMind Institute


Feb 24, 2026, 09:05 ET New Research Finds Heart Health Benefits in Combining Mango and Avocado Daily

findings.About the StudyThe study enrolled 82 generally healthy adults aged 25–60 with prediabetes, overweight or obesity (BMI 25–35 kg/m²) who were non-smokers, not on special diets, and free from major chronic conditions. Participants followed an 8-week, calorie-controlled

More news about: The National Mango Board


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.